美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
EZETIMIBE AND SIMVASTATIN	208699	001	ANDA	EZETIMIBE; SIMVASTATIN	TABLET;ORAL	10MG;10MG	No	No	2019/06/27	2019/06/27	GLENMARK PHARMS LTD	Prescription
EZETIMIBE AND SIMVASTATIN	208699	002	ANDA	EZETIMIBE; SIMVASTATIN	TABLET;ORAL	10MG;20MG	No	No	2019/06/27	2019/06/27	GLENMARK PHARMS LTD	Prescription
EZETIMIBE AND SIMVASTATIN	208699	003	ANDA	EZETIMIBE; SIMVASTATIN	TABLET;ORAL	10MG;40MG	No	No	2019/06/27	2019/06/27	GLENMARK PHARMS LTD	Prescription
EZETIMIBE AND SIMVASTATIN	208699	004	ANDA	EZETIMIBE; SIMVASTATIN	TABLET;ORAL	10MG;80MG	No	No	2019/06/27	2019/06/27	GLENMARK PHARMS LTD	Prescription
EZETIMIBE AND SIMVASTATIN	200082	001	ANDA	EZETIMIBE; SIMVASTATIN	TABLET;ORAL	10MG;10MG	No	No	2020/12/17	2020/12/17	AUROBINDO PHARMA USA	Prescription
EZETIMIBE AND SIMVASTATIN	200082	002	ANDA	EZETIMIBE; SIMVASTATIN	TABLET;ORAL	10MG;20MG	No	No	2020/12/17	2020/12/17	AUROBINDO PHARMA USA	Prescription
EZETIMIBE AND SIMVASTATIN	200082	003	ANDA	EZETIMIBE; SIMVASTATIN	TABLET;ORAL	10MG;40MG	No	No	2020/12/17	2020/12/17	AUROBINDO PHARMA USA	Prescription
EZETIMIBE AND SIMVASTATIN	200082	004	ANDA	EZETIMIBE; SIMVASTATIN	TABLET;ORAL	10MG;80MG	No	No	2020/12/17	2020/12/17	AUROBINDO PHARMA USA	Prescription
EZETIMIBE AND SIMVASTATIN	211663	001	ANDA	EZETIMIBE; SIMVASTATIN	TABLET;ORAL	10MG;10MG	No	No	2024/12/10	2024/12/10	SCIEGEN PHARMS INC	Prescription
EZETIMIBE AND SIMVASTATIN	211663	002	ANDA	EZETIMIBE; SIMVASTATIN	TABLET;ORAL	10MG;20MG	No	No	2024/12/10	2024/12/10	SCIEGEN PHARMS INC	Prescription
EZETIMIBE AND SIMVASTATIN	211663	003	ANDA	EZETIMIBE; SIMVASTATIN	TABLET;ORAL	10MG;40MG	No	No	2024/12/10	2024/12/10	SCIEGEN PHARMS INC	Prescription
EZETIMIBE AND SIMVASTATIN	211663	004	ANDA	EZETIMIBE; SIMVASTATIN	TABLET;ORAL	10MG;80MG	No	No	2024/12/10	2024/12/10	SCIEGEN PHARMS INC	Prescription